General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 1251: Which of the following statements is NOT true concerning amyloidosis?

A. Amyloidosis associated with multiple myeloma has the poorest prognosis.
B. Fine-needle biopsy of subcutaneous abdominal fat is a simple and reliable method for diagnosing secondary systemic amyloidosis.
C. Hepatic amyloid disease produces hepatomegaly but rarely jaundice.
D. Amyloidosis of the spleen is associated with severe anemia. (Correct Answer)

Explanation: ### Explanation **1. Why Option D is the Correct Answer (The False Statement):** Amyloidosis of the spleen (Splenic Amyloidosis) typically presents in two patterns: **Sago spleen** (deposits in splenic follicles) or **Lardaceous spleen** (deposits in splenic sinuses) [2]. While it causes significant splenomegaly, it is **not** typically associated with severe anemia. Anemia in amyloidosis is more commonly a result of chronic renal failure (due to AL or AA amyloidosis affecting the kidneys) or bone marrow infiltration in plasma cell dyscrasias, rather than the splenic involvement itself [1]. **2. Analysis of Incorrect Options (True Statements):** * **Option A:** AL (Amyloid Light chain) amyloidosis, often associated with **Multiple Myeloma**, has the poorest prognosis [1]. This is due to the high incidence of restrictive cardiomyopathy and heart failure, which are the leading causes of death in these patients [2]. * **Option B:** Abdominal fat pad biopsy (Fine-needle aspiration) is the preferred initial screening test for systemic amyloidosis. It is minimally invasive and has a high sensitivity (approx. 70-80%) for detecting Congo Red-positive deposits. * **Option C:** Hepatic amyloidosis frequently causes massive hepatomegaly and elevated alkaline phosphatase [2]. However, **jaundice is rare** and usually only occurs in terminal stages or with severe cholestatic variants. **3. Clinical Pearls for NEET-PG:** * **Staining:** Amyloid shows **Apple-green birefringence** under polarized light when stained with **Congo Red**. * **Structure:** All amyloid types share a **β-pleated sheet** tertiary structure [4]. * **Cardiac Involvement:** The most common cause of death in systemic amyloidosis [2]. * **Renal Involvement:** The most common clinical presentation of systemic amyloidosis (Nephrotic syndrome) [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 266-267. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 135-136. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 136-140. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-266.

Question 1252: The dominant histologic feature of infarction is:

A. Liquefactive necrosis
B. Coagulative necrosis (Correct Answer)
C. Chronic inflammation
D. Scar tissue

Explanation: **Explanation:** **1. Why Coagulative Necrosis is Correct:** Infarction is defined as an area of ischemic necrosis caused by the occlusion of either the arterial supply or the venous drainage [1]. In almost all solid organs (except the brain), the sudden loss of blood supply leads to **coagulative necrosis** [2]. The underlying mechanism involves the denaturation of structural proteins and enzymes (proteolysis). This denaturation blocks the proteolysis of the dead cells; as a result, the basic structural outline of the coagulated cells is preserved for several days, even though the cells are dead (often described as "tombstone appearance"). **2. Analysis of Incorrect Options:** * **A. Liquefactive Necrosis:** This is the dominant feature of infarction in the **Central Nervous System (brain)** and is also seen in focal bacterial or fungal infections (abscess formation) [4]. It is characterized by the digestion of dead cells into a liquid viscous mass. * **C. Chronic Inflammation:** This is a prolonged response to tissue injury or persistent infection, characterized by the presence of lymphocytes and macrophages. While it may follow an infarct during the healing phase, it is not the "dominant histologic feature" of the infarct itself. * **D. Scar Tissue:** This represents the end-stage of healing (fibrosis) after an infarct has occurred [3]. It is not the feature of the acute necrotic process. **3. High-Yield Clinical Pearls for NEET-PG:** * **Exception Rule:** Ischemia in the **Brain** results in Liquefactive necrosis, not Coagulative [4]. * **Morphology:** On H&E stain, coagulative necrosis shows increased eosinophilia (pinkness) and loss of nuclei (pyknosis, karyorrhexis, or karyolysis) [5]. * **Heart:** Myocardial infarction is the most common clinical example of coagulative necrosis. * **Wet vs. Dry Gangrene:** Dry gangrene is essentially coagulative necrosis of a limb, while wet gangrene involves superimposed liquefactive action by bacteria. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 140. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 53-55. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 140-142. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1268-1269. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 147-148.

Question 1253: Turner's Syndrome is associated with?

A. 45 chromosomes (Correct Answer)
B. Presence of Barr bodies
C. Low FSH levels
D. All of the above

Explanation: **Explanation:** **Turner’s Syndrome (45, XO)** is a genetic disorder caused by complete or partial monosomy of the X chromosome. It is the most common sex chromosome abnormality in females. 1. **Why Option A is Correct:** The hallmark of Turner’s Syndrome is the absence of one X chromosome, resulting in a total of **45 chromosomes (45, XO)**. This occurs due to non-disjunction during meiosis (most commonly paternal) [1]. 2. **Why Other Options are Incorrect:** * **Option B (Presence of Barr bodies):** A Barr body is an inactivated X chromosome. According to the Lyon hypothesis, the number of Barr bodies is equal to (Total X chromosomes - 1). Since Turner’s patients have only one X chromosome (1 - 1 = 0), they are **Barr body negative**. * **Option C (Low FSH levels):** Turner’s Syndrome is characterized by **"streak ovaries"** (gonadal dysgenesis). The lack of estrogen leads to a loss of negative feedback on the pituitary, resulting in **elevated** levels of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). This is a classic example of **hypergonadotropic hypogonadism**. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of primary amenorrhea.** * **Clinical Features:** Short stature (due to *SHOX* gene deletion), webbed neck (cystic hygroma), widely spaced nipples (shield chest), and cubitus valgus [1]. * **Cardiac Associations:** Bicuspid aortic valve (most common) and Coarctation of the aorta. * **Renal Association:** Horseshoe kidney. * **Genetics:** 50% are 45,XO; others are mosaics (e.g., 45,XO/46,XX) or have structural abnormalities (isochromosome Xq) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 168-177.

Question 1254: The odontogenic neoplasm, which is microscopically composed of loose, primitive-appearing connective tissue that resembles dental pulp, is known as _____.

A. Odontoma
B. Ameloblastoma
C. Ameloblastic fibroma
D. Odontogenic myxoma (Correct Answer)

Explanation: **Explanation:** The correct answer is **Odontogenic Myxoma**. This neoplasm is derived from the odontogenic ectomesenchyme (specifically the dental papilla, follicle, or periodontal ligament) [1]. **Why Odontogenic Myxoma is correct:** Microscopically, it is characterized by a **hypocellular** arrangement of stellate or spindle-shaped cells embedded in an abundant **mucoid/myxomatous extracellular matrix**. This appearance closely mimics the **primitive connective tissue of the dental pulp**. On imaging, it typically presents as a multilocular radiolucency with a characteristic **"soap bubble"** or **"honeycomb"** appearance, often showing "string-of-tennis-racket" bony trabeculations. **Why the other options are incorrect:** * **Odontoma:** These are hamartomas rather than true neoplasms [1]. They consist of mature enamel, dentin, cementum, and pulp tissue arranged either in a tooth-like shape (Compound) or a disorganized mass (Complex). * **Ameloblastoma:** This is an epithelial tumor, not mesenchymal [1]. It is characterized by islands of odontogenic epithelium with peripheral palisading cells (reverse polarity) and a central area resembling stellate reticulum. * **Ameloblastic Fibroma:** This is a mixed tumor (epithelial and mesenchymal). While it contains primitive-looking connective tissue, it must also feature islands and cords of odontogenic epithelium to satisfy the diagnosis. **NEET-PG High-Yield Pearls:** * **Histology Keyword:** "Stellate cells in a loose myxoid stroma." * **Radiology Keyword:** "Soap bubble" or "Tennis racket" appearance. * **Consistency:** Grossly, the tumor has a gelatinous or slimy consistency, making complete surgical removal difficult (high recurrence rate). * **Origin:** Derived from the **mesenchymal** component of the tooth germ [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 741-742.

Question 1255: Which marker is used to assess monoclonality in T-cells?

A. Kappa and Lambda chain
B. TCR gene rearrangement (Correct Answer)
C. CD
D. CD34

Explanation: ### Explanation **Correct Answer: B. TCR gene rearrangement** **Concept:** In pathology, "monoclonality" is the hallmark of malignancy [1]. For T-cells, assessing clonality is more complex than for B-cells because T-cells do not produce surface light chains. Instead, every mature T-cell possesses a unique **T-cell Receptor (TCR)** formed by the somatic rearrangement of V, D, and J gene segments [2]. * In a **reactive (polyclonal)** process, a population of T-cells will show diverse TCR gene patterns [1]. * In a **neoplastic (monoclonal)** process, such as T-cell lymphoma, all malignant cells are progeny of a single transformed cell and will share the **identical TCR gene rearrangement** [1]. This is detected using PCR or Southern Blotting [1]. **Analysis of Incorrect Options:** * **A. Kappa and Lambda chain:** These are immunoglobulin light chains used to assess monoclonality in **B-cells**. A normal ratio is roughly 2:1; a significant shift (e.g., all Kappa) indicates a monoclonal B-cell proliferation. [2] * **C. CD3:** This is a pan-T-cell marker used for **lineage identification** (confirming a cell is a T-cell), but it cannot distinguish between a benign reactive T-cell and a malignant one. * **D. CD34:** This is a marker for **hematopoietic stem cells** and early precursors. It is used to identify blasts in acute leukemia but does not indicate clonality. **High-Yield Clinical Pearls for NEET-PG:** * **B-cell clonality:** Assessed by Kappa/Lambda light chain restriction (via Flow Cytometry) or IgH gene rearrangement. * **T-cell clonality:** Assessed primarily by TCR gamma or beta gene rearrangement [1]. * **Gold Standard:** While PCR is faster and more common, **Southern Blotting** was historically the gold standard for detecting gene rearrangements. * **Exception:** Not all monoclonal populations are malignant (e.g., Monoclonal Gammopathy of Undetermined Significance - MGUS), but in the context of lymphoid masses, clonality strongly suggests lymphoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 342-343. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 155-156.

Question 1256: Which of the following proteins is known as the "guardian of the genome"?

A. p53 (Correct Answer)
B. Mdm2
C. p14
D. ATM

Explanation: **Explanation:** **p53 (The Correct Answer):** Known as the **"Guardian of the Genome,"** [1] p53 is a tumor suppressor protein encoded by the *TP53* gene on chromosome 17p [1]. It acts as a molecular policeman that monitors DNA integrity [2]. When DNA damage occurs, p53 levels rise and trigger three possible responses: 1. **Quiescence:** Temporary cell cycle arrest (at the G1-S checkpoint) via p21 induction to allow for DNA repair [1]. 2. **Senescence:** Permanent cell cycle arrest [1]. 3. **Apoptosis:** If repair fails, p53 induces pro-apoptotic genes (like BAX) [1] to eliminate the damaged cell. Loss of p53 function allows mutations to accumulate, leading to carcinogenesis. **Incorrect Options:** * **Mdm2:** This is the primary negative regulator of p53. It targets p53 for degradation. Overexpression of Mdm2 can lead to functional inactivation of p53, mimicking a mutation. * **p14 (ARF):** This protein acts as a tumor suppressor by inhibiting Mdm2, thereby stabilizing p53. It is a "helper" but not the guardian itself. * **ATM (Ataxia-Telangiectasia Mutated):** This is a protein kinase that senses double-stranded DNA breaks. It phosphorylates (activates) p53, acting as the "sensor," whereas p53 is the "effector." **High-Yield NEET-PG Pearls:** * **Li-Fraumeni Syndrome:** A germline mutation in *TP53* resulting in a high predisposition to multiple cancers (Sarcoma, Breast, Leukemia, Adrenal - SBLA). * **Most Common Mutation:** *TP53* is the most frequently mutated gene in human cancers [1]. * **HPV Link:** The E6 protein of High-risk Human Papillomavirus (HPV 16, 18) binds to and degrades p53. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 301-304. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 226-227.

Question 1257: Platelet activating factor causes all of the following except:

A. Vasoconstriction
B. Bronchodilation (Correct Answer)
C. Platelet aggregation
D. Signal transmission between cells

Explanation: **Explanation:** Platelet Activating Factor (PAF) is a potent phospholipid-derived mediator produced by various cells, including platelets, mast cells, neutrophils, and endothelial cells, via the action of phospholipase A2. **Why Bronchodilation is the correct answer:** PAF is a powerful **bronchoconstrictor**. It is approximately 100 to 1,000 times more potent than histamine in inducing bronchospasm. Therefore, it causes broncho-constriction, not dilation. This makes it a key mediator in the pathogenesis of asthma and anaphylactic reactions. **Analysis of incorrect options:** * **Vasoconstriction:** At high concentrations, PAF causes systemic vasoconstriction. However, it is unique because, at very low concentrations, it can cause vasodilation and increased vascular permeability (more potent than histamine). * **Platelet Aggregation:** As the name suggests, PAF’s primary function is to induce platelet aggregation and the subsequent release of platelet granules (degranulation). * **Signal Transmission:** PAF acts as a crucial signaling molecule. It binds to G-protein-coupled receptors (GPCRs) to trigger intracellular signaling pathways, facilitating communication between inflammatory cells and the endothelium. **High-Yield Clinical Pearls for NEET-PG:** * **Source:** Derived from membrane phospholipids by Phospholipase A2. * **Vascular Effects:** Causes wheal and flare reactions; it is a potent inducer of **increased vascular permeability** (leading to edema). * **Chemotaxis:** PAF is a strong chemoattractant for neutrophils and eosinophils. * **Leukocyte Activation:** It enhances leukocyte adhesion to endothelium, degranulation, and the oxidative burst.

Question 1258: Dystrophic calcification means:

A. Calcification in destroyed tissue with normal calcium level in blood (Correct Answer)
B. Calcium deposits
C. Calcification in normal tissue seen in hyperparathyroidism
D. Calcification in destroyed tissues with hypercalcemia

Explanation: ### Explanation **Dystrophic calcification** is a form of pathologic calcification that occurs in **dead, dying, or degenerated tissues** despite **normal serum calcium levels** and normal calcium metabolism. #### Why Option A is Correct: The hallmark of dystrophic calcification is its occurrence in damaged tissues (e.g., areas of necrosis, atherosclerosis, or damaged heart valves). The underlying mechanism involves the deposition of crystalline calcium phosphate. Crucially, the patient’s systemic calcium homeostasis remains intact; the process is localized to the site of injury. #### Why Other Options are Incorrect: * **Option B:** While it involves calcium deposits, this is too vague. Pathologic calcification is specifically categorized into Dystrophic or Metastatic based on the tissue state and serum levels. * **Option C:** This describes **Metastatic Calcification**. Metastatic calcification occurs in **normal tissues** due to **hypercalcemia** (often caused by hyperparathyroidism, Vitamin D toxicity, or bone resorption) [1], [2]. * **Option D:** This is a contradictory statement. If tissue is destroyed and there is hypercalcemia, it doesn't fit the classic definition of Dystrophic calcification, which specifically requires normal serum calcium levels. #### High-Yield NEET-PG Pearls: * **Morphology:** On H&E stain, it appears as gritty, white granules or clumps (basophilic/blue-purple). In metastatic cases, salts resemble those in dystrophic calcification [1]. * **Psammoma Bodies:** These are laminated, concentric calcifications seen in specific tumors (e.g., **P**apillary thyroid carcinoma, **S**erous cystadenocarcinoma of ovary, **M**eningioma, **M**esothelioma) [2]. * **Common Sites:** Atherosclerotic plaques, aging/damaged heart valves, and areas of caseous necrosis (e.g., old Tuberculosis). * **Initiation:** It starts in the mitochondria of dead cells or via membrane-bound vesicles in extracellular fluid. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 134-135.

Question 1259: A Barr body is absent in which of the following conditions?

A. Klinefelter syndrome
B. Turner syndrome (Correct Answer)
C. Super female syndrome (Triple X syndrome)
D. None of the above

Explanation: ### Explanation **1. Understanding Barr Bodies (The Lyon Hypothesis)** A Barr body is an inactivated X chromosome found in the somatic cells of females [1]. According to the Lyon hypothesis, in individuals with more than one X chromosome, all X chromosomes except one are inactivated to ensure dosage compensation. The number of Barr bodies is calculated using the formula: **Number of Barr bodies = (Total number of X chromosomes – 1).** **2. Why Turner Syndrome is the Correct Answer** * **Turner Syndrome (45, XO):** These individuals have only one X chromosome [1]. Applying the formula (1 – 1 = 0), they have **zero Barr bodies**. Since a Barr body represents an inactivated "extra" X chromosome, its absence is a hallmark of this condition. **3. Analysis of Incorrect Options** * **Klinefelter Syndrome (47, XXY):** Although phenotypically male, these individuals possess two X chromosomes [1]. One X chromosome undergoes inactivation, resulting in **one Barr body** (2 – 1 = 1). * **Super Female Syndrome (47, XXX):** These individuals have three X chromosomes. Two X chromosomes are inactivated, resulting in **two Barr bodies** (3 – 1 = 2). **4. NEET-PG High-Yield Clinical Pearls** * **Specimen Collection:** Barr bodies are most commonly demonstrated in **buccal mucosal smears** or "drumsticks" in polymorphonuclear leukocytes (neutrophils). * **Lyonization:** This process occurs early in embryonic life (around the blastocyst stage) and is random, fixed, and incomplete (some genes on the inactive X remain active) [1]. * **Rule of Thumb:** If the question asks for the number of Barr bodies, simply subtract 1 from the total number of X chromosomes present in the karyotype. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 173-175.

Question 1260: Which enzyme converts hydrogen peroxide to water and oxygen?

A. Superoxide dismutase
B. Catalase (Correct Answer)
C. Glutathione peroxidase
D. Myeloperoxidase

Explanation: **Explanation:** Free radicals or Reactive Oxygen Species (ROS) are neutralized by a specific battery of antioxidant enzymes. This question tests your ability to distinguish between their specific substrates and products. **1. Why Catalase is Correct:** Catalase is a major antioxidant enzyme primarily located in **peroxisomes**. It specifically catalyzes the decomposition of hydrogen peroxide ($H_2O_2$) into water and molecular oxygen ($2H_2O_2 \rightarrow 2H_2O + O_2$) [3]. This protects cells from oxidative damage and is one of the highest turnover-rate enzymes in the body [1]. **2. Analysis of Incorrect Options:** * **A. Superoxide dismutase (SOD):** Converts the superoxide radical ($O_2^{\bullet-}$) into hydrogen peroxide ($H_2O_2$) [1]. It acts upstream of catalase [3]. * **C. Glutathione peroxidase:** Also neutralizes $H_2O_2$, but it converts it into **water only** ($H_2O_2 + 2GSH \rightarrow GSSG + 2H_2O$), not oxygen [2]. It requires reduced glutathione and selenium as a cofactor. * **D. Myeloperoxidase (MPO):** Found in neutrophil granules, it converts $H_2O_2$ and chloride ions into **hypochlorous acid** (HOCl/bleach), which is a potent bactericidal agent rather than a neutralizing step. **Clinical Pearls for NEET-PG:** * **Fenton Reaction:** $H_2O_2$ in the presence of $Fe^{2+}$ produces the **Hydroxyl radical** ($\text{OH}^\bullet$), which is the most reactive and damaging ROS [3]. * **Chronic Granulomatous Disease (CGD):** Patients lack NADPH oxidase and are susceptible to **catalase-positive organisms** (e.g., *S. aureus*) because these bacteria destroy their own $H_2O_2$, leaving the host's deficient neutrophils with no substrate to produce HOCl. * **Cofactor Reminder:** SOD requires Copper/Zinc (cytosolic) or Manganese (mitochondrial); Glutathione peroxidase requires **Selenium**. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 100-101. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 59-60. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 59.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free